Vertex will make $21bn from cystic fibrosis drug
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more
Two Weston surgeries have been given £1.4 billion NHS funding between them as their financial situation is in a ‘mess’. … Read more